Skip to content
Lower risk Drug recall · FDA · Published September 28, 2017

Leading Pharma recalls 0.5mg lorazepam tablets labeled as 0.5mg but contain 1mg

Leading Pharma recalls 500-count lorazepam tablets labeled 0.5mg but contain 1mg. This labeling error may cause incorrect dosing. Consumers should contact the company for details.

🇺🇸 FDA recall #D-0085-2018DrugLeading Pharma ›
Take action

Contact the company

Recalling firmLeading Pharma, LLC3 Oak Rd · Fairfield, NJ 07004-2903
✎ GovInfoNow plain-language explainer

Leading Pharma is recalling 500-count lorazepam tablets that are labeled as 0.5mg but actually contain 1mg each. This labeling error could lead to incorrect dosing if taken as prescribed. Read more at govinfonow.com/recall/41161-leading-pharma-recalls-0-5mg-lorazepam-tablets-labeled-as-0.

Source Summary by GovInfoNow · govinfonow.com/recall/41161-leading-pharma-recalls-0-5mg-lorazepam-tablets-labeled-as-0 · Updated October 7, 2026 · FDA enforcement record: FDA #D-0085-2018

Cite this page

“Leading Pharma recalls 0.5mg lorazepam tablets labeled as 0.5mg but contain 1mg.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/41161-leading-pharma-recalls-0-5mg-lorazepam-tablets-labeled-as-0. Based on FDA recall #D-0085-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0085-2018%22&limit=1).

The FDA announced on September 28, 2017, that Leading Pharma, LLC voluntarily recalled Lorazepam Tablets, USP CIV, 0.5 mg, 500-count bottles due to a labeling error where the bottle contained 1mg tablets instead of the declared strength.

How to tell if you have it

  • Brand: Leading Pharma
  • Product: Lorazepam Tablets, USP CIV, 0.5 mg, 500-count bottle, Rx Only
  • Manufacturer: Leading Pharma, LLC Fairfield, NJ 07004
  • NDC: 69315-904-05
  • Lot #: E00717
  • Quantity: 2952 bottles
  • Distribution: Nationwide in the USA

The hazard

The hazard is a labeling error regarding the declared strength. The bottle labeled as containing 0.5 mg tablets actually contained 1mg tablets of lorazepam.

Context

GovInfoNow's records show Leading Pharma, LLC has had two other recalls since August 23, 2022, including a March 20, 2026 recall for Furosemide 80mg due to impurity and an August 23, 2022 recall for Clomipramine capsules with high drug content. Other recent recalls of similar products include Safecor Atomoxetine Capsules 10mg Mislabeled as 25mg (April 30, 2026), Meclizine 12.5mg Tablets Recall: Failed Tablet Specifications (March 16, 2026), and American Health Packaging Buprenorphine Tablets Recall: Label Mix-Up Hazard (August 19, 2026).

How to tell if you have this one

Check for the 500-count bottle labeled as 0.5mg with NDC 69315-904-05 and lot number E00717. The product is sold under the brand name Lorazepam.

  • Brand
    Leading Pharma
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for the label that states 0.5mg but contains 1mg of lorazepam.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 3 years after the firm started it.

1. Firm started the recall: Sep 28, 201712. FDA classified it Class II: Nov 20, 201723. Published in FDA’s Enforcement Report: Nov 29, 201734. FDA terminated the recall: Sep 21, 2020420172020
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Leading Pharma recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0085-2018 (September 28, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0085-2018 to see it in context.
  • Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA